Practice question
Question
The main purpose of using myeloma cells in hybridoma technology is:
Explanation
Primary B lymphocytes after differentiation short-lived plasma cells produce Ig extraordinary rate but survive 3-5 days culture due activation-induced death mediated Fas upregulation after strong BCR crosslinking and lack telomere maintenance somatic cells lacking telomerase entering senescence limited divisions dependence extrinsic survival signals CD40L helper T cells cytokines IL-4 IL-6 IL-21 follicular helper. Continuous monoclonal manufacturing over months requires immortalization essential. Myeloma plasmacytoma malignant transformation plasma cells proliferate indefinitely without exogenous growth factors due translocation placing oncogene c-myc under IgH enhancer driving cyclin D and constitutive IL-6 secretion creating autocrine loop activating JAK-STAT pathway promoting survival proliferation. Fusion with B cell transfers transformation phenotype granting hybridoma sustained division >100 passages cryopreservation stability preserving viability liquid nitrogen storage ability grow serum-free chemically defined bioreactors scaled 2000 L robust ER comprising chaperone BiP protein disulfide isomerase folding heavy light chains efficiently. While antibody specificity derives entirely B-cell partner rearranged Ig loci longevity continuous secretion originate myeloma component overcoming natural mortality limitation enabling long-term production and banking hybridoma lines.
Discussion
Comments
Share your thoughts. New comments appear after admin approval.
Please log in to join the discussion.
Login to commentNo comments yet. Be the first to start the discussion.